Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
05/2003
05/21/2003EP1312374A1 Sugar absorption inhibitors and process for producing the same
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311261A1 Medicaments for chemotherapeutic treatment of disease
05/21/2003EP1265884A4 A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities
05/21/2003EP1027316B1 Synthesis of aryl ethers, methods and reagents related thereto
05/21/2003EP0907646B1 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
05/21/2003CN1418877A Process for extracting vitamin E from plant-oil debrominated distillate
05/21/2003CN1418616A Cosmtics treatment using novel retinoid
05/21/2003CN1109034C Composition of gambogic acid compounds with anticancer activity and its preparing process
05/21/2003CN1109028C Microwave extraction method of ginkgolic flavone and bilobalide-like substances
05/20/2003US6566537 Tolterodine
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer
05/20/2003US6566071 Useful as fluorescent labeling reagents
05/20/2003US6566070 Detecting preferential protein biosynthesis; label nucleotide sequences, mix with translation system, incubate, detct signal from protein
05/20/2003US6565912 Production of isoflavone enriched fractions from soy protein extracts
05/20/2003CA2290004C Isoflavone rich protein isolate and process for producing
05/20/2003CA2248117C Photochromic naphthopyran compositions of neutral color
05/15/2003WO2003040382A1 Process for producing optically active chroman derivative and intermediate
05/15/2003WO2003040134A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
05/15/2003WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003WO2003040124A1 Process for production of high purity tocopherols
05/15/2003WO2003040123A1 Zeolites as matrices
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039461A2 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
05/15/2003US20030092852 Epoxy resin composition, cured article thereof, novel epoxy resin, novel phenol compound, and process for preparing the same
05/15/2003US20030092695 Hormone inhibitors; therapy for sexual disorders
05/15/2003US20030092675 Skin treatment using a new retinoid
05/15/2003US20030092144 Production of farnesol and geranylgeraniol
05/15/2003US20030091639 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/15/2003US20030091607 Wrinkle resistance; cosmetics
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465680A1 Piperazine derivatives having sst1 antagonistic activity
05/14/2003EP1309572A1 Silent mark for oil product and detection method thereto
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309326A1 A therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives
05/14/2003EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
05/14/2003EP1140888B1 Optical molecular sensors for cytochrome p450 activity
05/14/2003EP0797427B1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides
05/14/2003CN1418208A Reagents for the quantitation active oxygen
05/14/2003CN1418195A Therapeutic morpholino-substituted compounds
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1417208A Prepn and application in preparing cancer-treating medicine of mistletoe alkaloid
05/14/2003CN1108299C Method for extracting and separating natural vitamin E from soybeam deodorized material by supercritical CO2
05/14/2003CN1108298C Processes and intermediates for preparing substituted chromanol derivatives
05/14/2003CN1108297C Viformyl cumarins compound, process for preparing same and pharmaceutical composition contg. same
05/13/2003US6562866 A method for treating or preventing an elevated blood lipid level-related disease in a mammal, which comprises administering thereto an effective amount of rutin, quercetin or a mixture thereof.
05/13/2003US6562864 Catechin multimers as therapeutic drug delivery agents
05/13/2003US6562863 Partially purified cocoa extracts containing cocoa polyphenols
05/13/2003US6562794 Cosmetic and dermatological formulations comprising flavonoids
05/08/2003WO2003037884A2 Process for separation of tocopherols
05/08/2003WO2003037883A1 Manufacture of alpha- tocopherol
05/08/2003WO2003037882A1 Heterocyclic retinoid compounds
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037316A1 Peroxisome proliferator activated receptor ligands and process for producing the same
05/08/2003WO2003011224A3 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/08/2003WO2002094836A3 Methods for preparation and use of psorospermin analogs
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003CA2462206A1 Substituted thioacetamides
05/08/2003CA2460134A1 Peroxisome proliferator activated receptor ligand and process for producing the same
05/07/2003EP1308448A1 Method for the preparation of chromanone
05/07/2003EP1307586A2 Enzyme substrate
05/07/2003EP1307438A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
05/07/2003EP1307426A1 Amino diphenyl ethers and amido diphenyl ethers
05/07/2003EP1307189A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
05/07/2003EP1307188A1 Cannabinoid drugs
05/07/2003EP1307186A1 Methods for decreasing cell proliferation based on (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
05/07/2003EP1307184A2 Drugs for incontinence
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0799219B1 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
05/07/2003EP0792270B1 Use of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxy chroman (LLU-alpha)
05/07/2003CN1415609A Method for fast and high efficient extracting puerarin
05/07/2003CN1107677C Camptothecin derivatives and use thereof as antimutor agents
05/07/2003CN1107675C Method for super critical fluid extraction and concentration of natural vitamine E
05/06/2003US6559145 Heterocycle carboxamides as antiviral agents
05/06/2003US6558942 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
05/06/2003US6558655 Substituted with at least one hydroxyl group or alkoxy radical.
05/06/2003US6558583 Photochromism; opthalmic lenses; protective devices; tint
05/02/2003EP1306093A1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
05/02/2003EP1305327A2 Triphosphate oligonucleotide modification reagents and uses thereof
05/02/2003EP1305022A1 Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures
05/02/2003EP0854874B1 Macrocyclic lactone compounds and their production process
05/02/2003EP0811006B1 Benzopyran-containing compounds and method for their use
05/02/2003EP0775130B1 Method for the preparation of (+/-)-calanolide a and intermediates thereof
05/01/2003WO2003035693A2 Crystals of cytochrome p450 2c9, structures thereof and their use
05/01/2003WO2003035636A2 Process for the preparation of 3 - isochromanone
05/01/2003WO2003035635A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
05/01/2003US20030084479 Nucleic acid encoding a homogentisate phytyltransferase and a sequence encoding a plastid transit peptide, functionally linked to regulatory signals which ensure transcription and translation in prokaryotic or eukaryotic organisms
05/01/2003US20030083369 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity
05/01/2003US20030083270 Process for the production of (-)-epigallocatechin gallate
05/01/2003US20030082247 Obesity inhibitory materials
05/01/2003US20030082118 Use of substituted vinyltetrahydronaphthalenes and vinyl-benzotetrahydropyrans as light protection agents
05/01/2003CA2464593A1 6-hydroxy isoflavones, derivatives and medicaments involving same
04/2003
04/30/2003CN1414956A Substituted piperazine derivatives as MIP inhibitors
04/30/2003CN1414952A Heterocyclic compounds having sulfonic acid
1 ... 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 ... 242